Physician profile
James Perry
NPI 1710092135
$959.29
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $129 · 2021: $111 · 2022: $110 · 2023: $17.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $216.17 | 2019 | |
| Beigene USA, INC. | $110.00 | 2022 | |
| Mckesson Specialty Care Distribution, LLC | $99.60 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $69.14 | 2019-2023 | Imbruvica |
| Amgen INC. | $56.18 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $51.79 | 2019-2020 | |
| Astellas Pharma US INC | $46.16 | 2019-2021 | |
| Celgene Corporation | $38.90 | 2019 | |
| Tesaro, INC. | $34.57 | 2019 | |
| Genzyme Corporation | $32.83 | 2019-2020 | |
| Lilly USA, LLC | $28.64 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $22.81 | 2020 | |
| Eisai INC. | $21.66 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.14 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $15.49 | 2019 | |
| Merck Sharp & Dohme LLC | $15.40 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.48 | 2020 | |
| Alexion Pharmaceuticals, INC. | $13.42 | 2019 | |
| Foundation Medicine, INC. | $13.28 | 2019 | |
| Taiho Oncology, INC. | $12.09 | 2019 | |
| Seagen INC. | $12.08 | 2019 | |
| Clovis Oncology, INC. | $0.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.